Read More Pharma Industry News Why Alpha Cognition raised $35m now — And what it means for Alzheimer’s drugs Alpha Cognition (Nasdaq: ACOG) raises $35M in an oversubscribed public offering to drive Alzheimer’s therapy ZUNVEYL—see how investors are reacting. byPallavi MadhirajuOctober 1, 2025